바로가기메뉴

본문 바로가기 주메뉴 바로가기

Tuberculosis & Respiratory Diseases

Article Contents

Prev Next
e-Submission

Vol.86 No.3
Citation Share

Summary of Korean Asthma Guideline

Tuberculosis & Respiratory Diseases / Tuberculosis & Respiratory Diseases,
2023, v.86 no.3, pp.158-165
https://doi.org/10.4046/trd.2023.0052
Sang Yeub Lee, M.D., Ph.D. (Division of Respiratory and Critical Care Medicine, Department of Internal Medicine, Korea University Anam Hospital)
Chin Kook Rhee, M.D., Ph.D. (The Catholic University of Korea)
Ji‑Yong Moon, M.D., Ph.D. (2Department of Internal Medicine, Hanyang University Guri Hospital, Hanyang University College of Medicine, Guri)
Hyonsoo Joo, M.D., Ph.D. (Department of Internal Medicine, Uijeongbu St. Mary’s Hospital)
Ji Ye Jung, M.D., Ph.D. (Severance Hospital, Younsei University Health System, Yonsei University College of Medicine, Seoul)
Jung-Kyu Lee, M.D. (Seoul Metropolitan Government-Seoul National University Boramae Medical Center)
Kyung Hoon Min, M.D., Ph.D. (Division of Pulmonary, Allergy and Critical Care Medicine, Department of Internal Medicine, Korea Un)
Hyeon-Kyoung Koo, M.D., Ph.D. (Inje University Ilsan Paik Hospital, Inje University College of Medicine)
Seong Yong Lim, M.D., Ph.D. (Division of Pulmonary and Critical Care Medicine, Department of Medicine, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul)
Hyoung Kyu Yoon, M.D., Ph.D. (Yeouido St. Mary’s Hospital, College of Medicine, The Catholic University of Korea)
the Korean Asthma Study Group in The Korean Academy of Tuberculosis an (the Korean Asthma Study Group in The Korean Academy of Tuberculosis and Respiratory Diseases (KATRD)
Sang, Y. L. M. P. , Chin, K. R. M. P. , Ji‑Yong, M. M. P. , Hyonsoo, J. M. P. , Ji, Y. J. M. P. , Jung-Kyu, L. M. , Kyung, H. M. M. P. , Hyeon-Kyoung, K. M. P. , Seong, Y. L. M. P. , Hyoung, K. Y. M. P. , & the, K. A. S. G. i. T. K. A. o. T. a. (2023). Summary of Korean Asthma Guideline. Tuberculosis & Respiratory Diseases, 86(3), 158-165, https://doi.org/10.4046/trd.2023.0052
  • Downloaded
  • Viewed
PDF Download

Abstract

Asthma is a chronic inflammatory airway disease that is characterized by variable airflowobstruction. The Korean Asthma Study Group of the Korean Academy of Tuberculosisand Respiratory Diseases has recently updated the Korean Asthma Guideline. This review summarizes the updated Korean Asthma Guideline. Asthma prevalence isincreasing worldwide, and in Korea. Variable airflow obstruction can be confirmed bybronchodilator response or other tests, and should be established prior to the controllermedication. A low-dose inhaled corticosteroid-formoterol is used to alleviate symptomsin all treatment step, and it can be used as a controller as well as reliever in steps3–5. This approach is preferred, because it reduces the risk of severe exacerbations,compared to the use of short-acting β2-agonist as reliever. In severe asthma, phenotype/endotype based on the underlying inflammation should be evaluated. For type 2severe asthma, the biologics should be considered.

keywords
Asthma, Guideline, Korea

Tuberculosis & Respiratory Diseases

e-Submission OA Policy